Correlation Between Histogen and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Histogen and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Histogen and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Histogen and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Histogen and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Histogen with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Histogen and Cyclacel Pharmaceuticals.
Diversification Opportunities for Histogen and Cyclacel Pharmaceuticals
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Histogen and Cyclacel is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Histogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Histogen are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Histogen i.e., Histogen and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Histogen and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days Histogen is expected to generate 2.18 times more return on investment than Cyclacel Pharmaceuticals. However, Histogen is 2.18 times more volatile than Cyclacel Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest 17.00 in Histogen on August 29, 2024 and sell it today you would lose (15.00) from holding Histogen or give up 88.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Histogen vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| Histogen |
| Cyclacel Pharmaceuticals |
Histogen and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Histogen and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Histogen and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Histogen position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| Histogen vs. PayPal Holdings | Histogen vs. Nasdaq Inc | Histogen vs. Choice Hotels International | Histogen vs. Microsoft |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |